about
Targeting T cells to treat atherosclerosis: odyssey from bench to bedsideHow Mouse Macrophages Sense What Is Going On.Influence of immunoglobulin isotype on therapeutic antibody functionRole of Tumor Necrosis Factor Superfamily in Neuroinflammation and AutoimmunityTumor necrosis factor-α inhibitors and chronic hepatitis C: a comprehensive literature reviewInflammatory pathways of importance for management of inflammatory bowel disease4-1BB Agonists: Multi-Potent Potentiators of Tumor ImmunityThe Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunityA novel antagonist of p75NTR reduces peripheral expansion and CNS trafficking of pro-inflammatory monocytes and spares function after traumatic brain injury.NANOMEDICINE: will it offer possibilities to overcome multiple drug resistance in cancer?Regulation of tumour necrosis factor signalling: live or let dieGalectin-9 controls the therapeutic activity of 4-1BB-targeting antibodiesNF-κB signalling and cell fate decisions in response to a short pulse of tumour necrosis factor.Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral ReservoirsTWEAK mediates inflammation in experimental atopic dermatitis and psoriasis.T follicular helper expansion and humoral-mediated rejection are independent of the HVEM/BTLA pathwayProinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flareTranscription of the gene encoding TNF-α is increased by IL-1β in rat and human islets and β-cell linesTransient TNF regulates the self-renewing capacity of stem-like label-retaining cells in sphere and skin equivalent models of melanoma.Predictive gene signature of response to the anti-TweakR mAb PDL192 in patient-derived breast cancer xenograftsOzanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1 ) and receptor-5 (S1P5 ) agonist with autoimmune disease-modifying activity.Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interactionEnsemble of gene signatures identifies novel biomarkers in colorectal cancer activated through PPARγ and TNFα signalingEvaluation of the Effects of Some Brazilian Medicinal Plants on the Production of TNF- α and CCL2 by THP-1 Cells.TNF superfamily protein-protein interactions: feasibility of small- molecule modulationCorrelating RANK ligand/RANK binding kinetics with osteoclast formation and functionBasophil-associated OX40 ligand participates in the initiation of Th2 responses during airway inflammationNitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB.γ-Secretase directly sheds the survival receptor BCMA from plasma cellsThe Tumor Necrosis Factor Superfamily Molecule LIGHT Promotes Keratinocyte Activity and Skin Fibrosis.Haematological malignancies: at the forefront of immunotherapeutic innovation.Tumor necrosis factor superfamily 14 (LIGHT) controls thymic stromal lymphopoietin to drive pulmonary fibrosis.Peripheral Organs of Dengue Fatal Cases Present Strong Pro-Inflammatory Response with Participation of IFN-Gamma-, TNF-Alpha- and RANTES-Producing Cells.TB-IRIS, T-cell activation, and remodeling of the T-cell compartment in highly immunosuppressed HIV-infected patients with TBA transcriptome multi-tissue analysis identifies biological pathways and genes associated with variations in feed efficiency of growing pigsA Novel Galectin-1 Inhibitor Discovered through One-Bead Two-Compound Library Potentiates the Antitumor Effects of Paclitaxel in vivo.The TNF Receptor Superfamily in Co-stimulating and Co-inhibitory ResponsesTherapeutic antibodies that target inflammatory cytokines in autoimmune diseasesFabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo.Distinct NF-κB and MAPK Activation Thresholds Uncouple Steady-State Microbe Sensing from Anti-pathogen Inflammatory Responses.
P2860
Q26740179-94D793A3-709A-4A69-AC78-CB491CAC472EQ26745544-650862E3-EACA-4E52-83B5-6C5768BE1753Q26772080-506F4C17-5E2A-46B6-AF6C-B59079086D37Q26800155-55DD6E03-C5F9-4668-BFBA-7C88ECC698D5Q26829390-2337723E-7C04-43F4-B561-86BE60A49CFBQ27005445-30DECA5D-36BA-4F53-B912-3FD60BFB03DBQ27012963-6F9C6FA9-4872-4480-8278-46D08F87A889Q27025082-49B04989-BCC5-4570-B844-41B0AF0945D2Q27303179-55BB0553-50D3-41D9-9B96-0C53AD695DF4Q28078448-3FEF0CEE-D0C7-4CE5-B735-47EB5CE59E52Q28262381-3DE3D11D-3895-4650-97B6-851F796FB4DAQ28656460-BF0868E4-EADD-4FD0-B3A6-3668C1AD4705Q30832764-98AAC960-527F-424C-ACFB-C10DDF457E40Q33613493-2B49A87E-CBE1-438A-B730-E68497C69E68Q33860715-7ABB1FA3-5C50-43A6-9135-993D10353757Q33920121-EF0ED138-5F39-4EF3-A5A3-8EA77851857BQ34025881-032460A5-CA07-467B-A182-E57738D84A7CQ34146626-66B64CED-5338-4374-8ED0-5142CD61C920Q34233871-B40BA3CE-97A3-4909-8263-93C8882BC554Q34465302-DF64553D-EBD4-4F14-836D-408E33A9C333Q34518822-2735EAF3-A782-42B1-B78C-3A167C7D039DQ34954124-E4AF2AB5-FF88-48BF-97AA-7E36E8C55820Q35019555-4A670E0F-9D88-43AF-8EF4-24A08AB84DE4Q35279021-C427BFA2-7671-4CB7-9634-04AE8C1FCA83Q35534271-5B57F835-3714-4E90-9C80-C2585DDC985EQ35599724-0ED1B17E-96FC-44E2-B0FF-4E7CC536EF96Q35608058-A0CA6417-24AC-4BDD-8262-16D945DE7434Q35612396-5296E050-1412-4BFA-8986-23ED997D981FQ35814239-8C3951B3-BF87-4A94-8884-81C8BA4BC734Q35858686-E04A7E82-EFD2-4E9A-83A6-A7D890D296F2Q35880618-729B9DB2-E7BA-4D9A-BB89-E872F4BC235FQ35941021-05B6B137-1316-4F1D-976F-5E4899B2E35FQ36231756-2D82F73F-E922-4421-8415-3820D82B42CAQ36292332-881A9BB2-758D-4EB6-8C0B-3682F8BA0951Q36317314-DC4CD739-06AF-402C-818F-E2C8EF1423FEQ36342596-72DC8994-5F5D-42DD-B54B-EB4685B1CB12Q36940326-DF1FDBF5-52AA-4987-BAC2-4C44090BE28BQ36958902-B855328E-3FEB-4A6C-B70B-0D431E63F909Q37003881-B38AA3C5-EBD7-4345-8833-CED9471C027FQ37033724-32243D28-BC28-440A-92B1-68B11E67350D
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Clinical targeting of the TNF and TNFR superfamilies
@ast
Clinical targeting of the TNF and TNFR superfamilies
@en
type
label
Clinical targeting of the TNF and TNFR superfamilies
@ast
Clinical targeting of the TNF and TNFR superfamilies
@en
prefLabel
Clinical targeting of the TNF and TNFR superfamilies
@ast
Clinical targeting of the TNF and TNFR superfamilies
@en
P2093
P2860
P356
P1476
Clinical targeting of the TNF and TNFR superfamilies
@en
P2093
Carl F Ware
Chris A Benedict
Michael Croft
P2860
P2888
P304
P356
10.1038/NRD3930
P577
2013-01-21T00:00:00Z